Welcome to our dedicated page for Avalon Globocare SEC filings (Ticker: ALBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Avalon GloboCare Corp. filings document public-company disclosures for its consumer diagnostics, generative AI software, intellectual property, and capital structure. Recent 8-K reports cover material events involving Avalon Quantum AI LLC, the Catch-Up AI video platform, Nasdaq listing-compliance notices, shareholder communications, and pro forma financial information tied to the completed sale of Avalon RT 9 Properties, LLC.
The company’s proxy and registration filings describe board elections, auditor ratification, equity incentive-plan matters, advisory compensation votes, Nasdaq-rule approvals for warrant share issuance, and securities registration matters. Avalon’s filings also address common stock, warrants, pre-funded warrants, shareholder voting mechanics, governance procedures, operating and financial results, and risk disclosures for a smaller reporting company.
Avalon GloboCare Corp. is asking stockholders to approve several financing-related actions and a potential reverse stock split at a March 30, 2026 virtual special meeting. Holders of 6,264,740 common shares as of February 17, 2026 can vote.
The Company seeks approval for conversions tied to July 2025 convertible notes, a December 2025 bridge note plus 100,000 commitment shares, and its Series C preferred stock, each needed to comply with Nasdaq Listing Rule 5635(d) because conversions could exceed 20% of prior outstanding shares.
Stockholders are also asked to approve exchanging 5,000 Series D preferred shares held by Chairman Wenzhao Lu for 2,074,689 common shares, issuing 450,000 restricted shares to an advisor, and authorizing a reverse stock split at a ratio between 1‑for‑2 and 1‑for‑25, without reducing authorized common shares, to help maintain Nasdaq listing and potentially broaden investor interest. An adjournment proposal would allow extra time to solicit votes if needed. The Board unanimously recommends voting “FOR” all proposals.
Avalon GloboCare Corp. entered into a private placement with institutional investors, raising approximately $3.25 million gross through the sale of 6,372,550 shares of common stock (or pre-funded warrants in lieu) at $0.51 per share, plus accompanying Series A-1 and Series A-2 warrants.
The company expects net proceeds of about $2.8 million, which it plans to use to repay certain outstanding debt and for working capital and general corporate purposes. The warrants, covering up to 12,745,100 shares, carry a $0.51 exercise price and become exercisable after stockholder approval, with expirations five years and eighteen months from that approval, respectively.
Avalon GloboCare Corp. filed a current report describing that it has been accepted into the AMD AI Developer Program. This gives Avalon access to AMD Developer Cloud credits, advanced tools, training, and community resources aimed at supporting and accelerating artificial intelligence development.
Avalon plans to use these resources mainly through its AI-focused subsidiary Avalon Quantum AI LLC (AQAI) to scale automated commentary video generation, future enterprise documentation tools, and an AI-powered workflow automation platform. Management highlights this as part of Avalon’s broader repositioning as a technology-focused AI company.
Avalon GloboCare Corp. filed a current report describing that it has been accepted into the AMD AI Developer Program. This gives Avalon access to AMD Developer Cloud credits, advanced tools, training, and community resources aimed at supporting and accelerating artificial intelligence development.
Avalon plans to use these resources mainly through its AI-focused subsidiary Avalon Quantum AI LLC (AQAI) to scale automated commentary video generation, future enterprise documentation tools, and an AI-powered workflow automation platform. Management highlights this as part of Avalon’s broader repositioning as a technology-focused AI company.
Avalon Globocare Corp. entered a financing deal with an accredited investor, issuing a promissory note with a principal amount of $233,910 (including a $26,910 original issue discount) for gross proceeds of $207,000. The note carries a one-time interest charge of $28,069 (12% of principal), matures on February 15, 2027, and can accrue default interest at 22% per year if unpaid.
The note can be prepaid at 96–98% of principal plus interest depending on timing, and is scheduled for a $144,088 payment on August 15, 2026, followed by monthly installments of $19,648.50 from September 15, 2026 through maturity. Upon an event of default, it becomes immediately due at 150% of outstanding amounts and may be converted into common stock at 75% of market price, subject to a 4.99% beneficial ownership cap and a 19.99% limit relative to shares outstanding on the issuance date without prior stockholder approval.
The filing also reports that directors William B. Stilley III, Wilbert J. Tauzin II and Tevi Troy resigned from the board on February 24, 2026, not due to any disagreement with the company. On the same date, the board appointed Lourdes Felix, Michael Mathews and Steven Sanders to key committee and leadership roles, including audit committee chair, nominating and corporate governance committee chair, and lead independent director.
Avalon GloboCare Corp. director Michael Mathews reported receiving 1,364.840 shares of the company’s Series E Non-Voting Convertible Preferred Stock at a stated price of $0 per share. These preferred shares were issued in exchange for 2,600,000 common shares of RPM Interactive, Inc. as part of Avalon GloboCare’s acquisition of RPM.
Each share of this Series E preferred stock is perpetual, so it has no expiration date, and it becomes convertible into Avalon GloboCare equity at any time from and after May 12, 2026, or earlier if the company consents in writing.
Avalon GloboCare Corp. director Mathews Michael filed an initial insider ownership report on Form 3. The filing establishes his status as a director of the company but does not list any specific share transactions or changes in ownership.
Avalon Globocare Corp. completed an amended transaction to sell 100% of the membership interests of its subsidiary Avalon RT 9 Properties, LLC, which owns the company’s Freehold, New Jersey office property, to its board chairman Wenzhao Lu.
The amended deal provides total consideration of $9,000,000, consisting of $3,100,000 in cash previously advanced under the original agreement and the satisfaction in full of an approximately $5,900,000 mortgage balance. Following closing, Avalon is released from all obligations as guarantor on that mortgage.
The company also amended a $375,000 unsecured bridge note dated December 11, 2025, extending the first, second, and third payment deadlines to March 16, 2026, April 15, 2026, and May 15, 2026, respectively.
Avalon Globocare Corp. entered into a financing deal with Vanquish Funding Group involving a $233,910 promissory note, sold for $207,000 with a $26,910 original issue discount and a one-time 12% interest charge. The note requires seven monthly payments starting August 15, 2026 and matures on February 15, 2027. If an event of default occurs, the lender can demand 150% of the default amount and the note becomes convertible into common stock at 75% of the lowest trading price over the prior ten trading days, subject to a 19.99% issuance cap. Avalon plans to use the proceeds for general working capital and paid a $10,000 fee to Digital Offering LLC. The company also issued 300,000 common shares to consultants for services rendered, receiving no cash proceeds.
Avalon GloboCare Corp. is convening a virtual special meeting on to seek stockholder approval for seven proposals that would clear Nasdaq compliance for multiple equity-related transactions and permit a reverse stock split.
The items include approvals to potentially issue shares on conversion of July 2025 and December 2025 notes (seeking relief for up to 485,816 and 890,321 shares, respectively), approval to permit conversion of Series C convertible preferred stock, approval of an exchange of Series D preferred for 2,074,689 common shares to the Chairman, issuance of 450,000 restricted shares to an advisor, authority to effect a reverse split between 1-for-2 and 1-for-25, and an adjournment proposal.
Avalon GloboCare Corp. reported that its subsidiary, Avalon Quantum AI LLC, filed a third U.S. provisional patent for its Catch-Up generative AI video platform. The application, titled “Systems and Methods for Audience-Adaptive Generation of Evidence-Preserving Commentary Video Variants” (No. 63/961,892), was filed on February 18, 2026.
The technology is designed to create multiple personalized commentary video versions from a shared, verified evidence framework while preserving factual integrity. It tailors structure, tone, pacing, and presentation for different audience segments and formats, with potential uses in financial commentary, sports highlights, and brand-safe marketing content.